Invirase (Genentech, Inc.)
Welcome to the PulseAid listing for the Invirase drug offered from Genentech, Inc.. This HIV Protease Inhibitors [MoA],Protease Inhibitor [EPC],Cytochrome P450 3A Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Genentech, Inc. |
| NON-PROPRIETARY NAME: | saquinavir mesylate |
| SUBSTANCE NAME: | SAQUINAVIR MESYLATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | HIV Protease Inhibitors [MoA],Protease Inhibitor [EPC],Cytochrome P450 3A Inhibitors [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | CAPSULE |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 1995-12-06 |
| END MARKETING DATE: | 0000-00-00 |
Invirase HUMAN PRESCRIPTION DRUG Details:
| Item Description | Invirase from Genentech, Inc. |
| LABELER NAME: | Genentech, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 200(mg/1) |
| START MARKETING DATE: | 1995-12-06 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0004-0245_6d9b8bd6-0351-4c02-a0e4-ee880b9a26e5 |
| PRODUCT NDC: | 0004-0245 |
| APPLICATION NUMBER: | NDA020628 |
Other SAQUINAVIR MESYLATE Pharmaceutical Manufacturers / Labelers:
